Schisandrin A (SchA), a good anti-cancer drug, significantly down-regulated EGFR, PIK3R1, and MMP9 but up-regulated cleaved-caspase 3, thus inhibiting the migration and promoting the apoptosis of MDA-MB-231 cells [29]. The gene discussed is CASP3; the disease is cancer.